05:42 EDT Sanofi (SNY) to acquire Blueprint Medicines (BPMC) for $129 per share in cash
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BPMC:
- M&A News: Sanofi Expands Cancer Drug Portfolio with $9.1B Blueprint Medicines Acquisition
- ‘Stay Invested’: Wells Fargo Suggests 2 Stocks to Ride the Market Recovery
- Blueprint Medicines’ Ayvakit Poised to Maintain Market Leadership Amidst Competitive Challenges
- Cautious Optimism: Blueprint Medicines’ Hold Rating Amid Mixed Growth Signals
- Blueprint Medicines: Strong Market Position and Growth Potential Justify Buy Rating with $135 Price Target